| DB ID | MyCo_3661 |
| Title | Two Gene Set Variation Index as Biomarker of Bacterial and Fungal Sepsis |
| Year | 2020 |
| PMID | 32596378 |
| Fungal Diseases involved | Fungal sepsis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | None |
| Site of Infection | Unspecified |
| Opportunistic invasive | None |
| Sample type | None |
| Sample source | NA |
| Host Group | NA |
| Host Common name | NA |
| Host Scientific name | NA |
| Biomarker Name | EFR2 |
| Biomarker Full Name | EFR2 |
| Biomarker Type | Diagnostic |
| Biomolecule | Gene |
| Geographical Location | China |
| Cohort | None |
| Cohort No. | None |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | Sepsis is a life-threatening disease characterized by systemic inflammation caused by infection. It usually occurs after infection with virus, fungi, and bacteria. At present, sepsis incidence is estimated at 270 cases per 100,000 per- sons/year followed by an approximately 26% mortality rate, potentially 5.3 million deaths annually in the world. |
| Sub Technique | Transcriptomics |
| Technique | Computational |
| Analysis Method | Gene set variation analysis (GSVA) |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Gene set variation analysis (GSVA) |
| Up Regulation Down Regulation | Up regulated |
| Sequence Data | None |
